Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, GSK
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's High Court. Pfizer and BioNTech had filed their lawsuit in September 2022 over patents relating to messenger RNA (mRNA) technology,
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion in Pfizer as the pharmaceutical giant grapples with a downturn in demand for COVID-19 vaccines and treatments.
U.K. court rules in Pfizer's favor in GSK RSV vaccine dispute: report
Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine. Read more here.
Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus (RSV) vaccine.
Starboard Takes $1B Stake In Pfizer
Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help
Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its COVID-19 products.
Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic waned.
Activist investor Starboard has informed Pfizer it has taken a stake
Activist investor Starboard Value is looking to shake up pharma giant Pfizer's sagging stock price.
7h
on MSN
What Doctors Want You to Know About Choosing a COVID Vaccine in 2024
Which COVID vaccine is better? It’s hard to say that one is better than the other. “Antibody studies have shown that the mRNA ...
8h
Pfizer: A 6% Yielding Ultra SWAN Bargain With Upside Potential
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...
9h
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
13d
Pfizer Is Rising Past Covid-19
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
4d
on MSN
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...
1d
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
CNET on MSN
3d
Novavax Is Here for the COVID Fight: What to Know About the Vaccine
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
InvestmentNews
1d
Wall Street unsure about Pfizer, but Starboard just bought $1M stake
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Starboard
pharma
Ian Read
Feedback